Business Description

Description
Genix Pharmaceuticals Corp is a Canadian life sciences company. It operates as a formulator, manufacturer, licensor, and marketer of life sciences-related products with a focus on nutraceuticals and pharmaceuticals.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.02
Equity-to-Asset -4.84
Debt-to-Equity -0.48
Debt-to-EBITDA -0.15
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -129
Distress
Grey
Safe
Beneish M-Score -15.56
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -109.1
3-Year EPS without NRI Growth Rate 15.7

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 0.23
9-Day RSI 4.29
14-Day RSI 13.99
6-1 Month Momentum % -13.33
12-1 Month Momentum % -26.97

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.17
Quick Ratio 0.05
Cash Ratio 0.01
Days Inventory 6618.67
Days Sales Outstanding 272.09
Days Payable 10901.33

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -7.79

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 18.18
Operating Margin % -6372.73
Net Margin % -38427.27
FCF Margin % -1975
ROE % -355.15
ROA % -169.16
ROIC % -21.47
ROC (Joel Greenblatt) % -166400
ROCE % -349.64
Years of Profitability over Past 10-Year 2

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -0.99
EV-to-EBITDA -1.1
EV-to-Revenue 374.55
EV-to-FCF -19.34
Earnings Yield (Greenblatt) % -101.01
FCF Yield % -5.99

Financials

GENPF's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:GENPF

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Genix Pharmaceuticals Corp Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.008
EPS (TTM) ($) -0.05
Beta 4.92
Volatility % 158.1
14-Day RSI 13.99
14-Day ATR ($) 0.00014
20-Day SMA ($) 0.026
12-1 Month Momentum % -26.97
52-Week Range ($) 0.0138 - 0.0454
Shares Outstanding (Mil) 59.22

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Genix Pharmaceuticals Corp Filings

Filing Date Document Date Form
No Filing Data

Genix Pharmaceuticals Corp Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Genix Pharmaceuticals Corp Frequently Asked Questions

What is Genix Pharmaceuticals Corp(GENPF)'s stock price today?
The current price of GENPF is $0.03. The 52 week high of GENPF is $0.05 and 52 week low is $0.01.
When is next earnings date of Genix Pharmaceuticals Corp(GENPF)?
The next earnings date of Genix Pharmaceuticals Corp(GENPF) is .
Does Genix Pharmaceuticals Corp(GENPF) pay dividends? If so, how much?
Genix Pharmaceuticals Corp(GENPF) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1